Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Instrumentation

Instrumentation firm Bruker invests in ‘omics’ with 2 acquisitions

by Craig Bettenhausen
January 23, 2022 | A version of this story appeared in Volume 100, Issue 3

 

The instrumentation firm Bruker has made two investments in proteomics and related techniques by buying the low-flow chromatography specialist Prolab Instruments and assembling a controlling interest in the mass spectrometry proteomics sample prep firm PreOmics. Prolab makes pumps and other equipment for liquid chromatography flow rates of between 4 nL/min and 10 µL/min. PreOmics is a 2016 Max Planck Institute spin-off. Bruker intends to integrate technology from both firms into its timsTOF 4D proteomics system and other “omics” instrumentation.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.